WILMINGTON, Del., Dec. 30, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (NRXP) ("NRx", the "Company"), a clinical-stage biopharmaceutical company, today announced the transmission of first section ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results